DHA patent revoked
This article was originally published in The Tan Sheet
Executive Summary
Martek Biosciences to appeal recent DHA patent revocation in Europe, firm says Oct. 12. Martek's patent was annulled by the European Patent Office at a recent hearing held in Munich, Germany following a challenge by several potential competitors. The infant formula and dietary supplement ingredients supplier recently received a separate European patent for the production, sale and use of ARA (1"The Tan Sheet" Sept. 25, In Brief)